Shijie Zhou

Years Active: 2017-2022
Publications (10 Years): 5

Sichuan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Sichuan University Sep 01 2018

China

PHD :: Cancer Center

Publications

Chunmei Hu, Jiangang Fan, Gang He, Chuan Dong, Shijie Zhou, Yun Zheng
Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma. PloS one 17 (6) (2022)
Bowen Hu, Shijie Zhou, Xuefeng Hu, Hua Zhang, Xiaorong Lan, Mei Li, Yunbing Wang, Qinsheng Hu
NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop. Journal of cellular and molecular medicine (2021)
Zhao Xiang, Shijie Zhou, Shuang Liang, Gang Zhang, Yinghui Tan
RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 49 (8) (2020)
Qinsheng Hu, Shijie Zhou, Xuefeng Hu, Hua Zhang, Shishu Huang, Yunbing Wang
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma. Journal of cellular and molecular medicine 24 (1) (2019)
Shijie Zhou, Ping Wang, Xiaolan Su, Jingxia Chen, Hongfen Chen, Hanbing Yang, Aiping Fang, Linshen Xie, Yuqin Yao, Jinliang Yang
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. PloS one 12 (10) (2017)

Shijie Zhou.css-eqlu8i{font-size:small;padding-left:4px;}